IsOncoMed Pharmaceuticals (NASDAQ:OMED) An Attractive Buy? Wells Fargo Initiates Coverage
How Wells Fargo Currently Rates OncoMed Pharmaceuticals (NASDAQ:OMED) Stock analysts at Wells Fargo began issuing coverage on OncoMed Pharmaceuticals (NASDAQ:OMED) with “Outperform” rating. This was…
